$1.20
$0.00
(0.00%)
Quote as of 3:55 PM EST on 02/10/12
Idera Pharmaceuticals, Inc.
NASDAQ:IDRA
Related Resources
IDRA
vs. S&P 500
|
$1.20
$0.00
(0.00%)
|
|
| Today's Open | $1.20 |
|---|---|
| Previous Close | $1.20 |
| Daily Range | $1.15 - $1.25 |
| 52-Week Range | $0.95 - $3.10 |
| Market Cap | $33.16M |
| P/E Ratio | -1.35 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 17,400 |
| Average Daily Volume | 30,933 |
| Current FY EPS | -$0.88 |
IDRA Information
| Description |
|---|
| The Company is engaged in the discovery and development of synthetic DNA and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Idera: FDA Orders Hold On Midstage Trial Of Psoriasis Treatment
7/20/2011 by Smart Money
Idera Pharma Postpones Phase 2 Trial of Hepatitis C Treatment
4/22/2011 by Smart Money
15 Biotech Stocks With the Lowest Put/Call Ratios
10/13/2010 by Seeking Alpha
Two IPOs Brave the Markets, Two Enter the Queue: Biotech's Latest Deals
8/8/2010 by Seeking Alpha
